Search

Search Results
Results 1081 - 1090 of 5971 for Drugs
  • Supplier Profile
    Promimic is a biomaterial company founded in 2004 as a spin-off from research performed at Chalmers University of Technology in Gothenburg, Sweden. The company develops and markets a new generation of...
  • Supplier Profile
    At JASCO International we aim to address the ever-changing analytical needs of our customers worldwide, by providing the very highest standards in analytical instrumentation. At the start of the...
  • Supplier Profile
    Nanomi develops membrane emulsification process technology and equipment for: monodisperse emulsions monodisperse double emulsions monodisperse microspheres (e.g. drug delivery...
  • Supplier Profile
    Micralyne is one of the largest independent MEMS foundries in the world. As an industry innovator and leader, Micralyne has a reputation of offering unparalleled MEMS product development and...
  • Supplier Profile
    Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new...
  • Supplier Profile
    Corning is one of the world's leading innovators in materials science, with a 169-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science,...
  • Supplier Profile
    Monogram is a leader in developing and commercializing innovative products to help guide and improve the treatment of infectious diseases, cancer and other serious diseases. Our molecular diagnostics...
  • News - 6 Jul 2022
    Glioblastoma (GBM) is a malignant brain cancer in adults with a median survival period of 15 months from the point of diagnosis. Residual tumor cells that remain beyond the margins of every GBM...
  • News - 29 Nov 2017
    A new method for delivering chemotherapy nanodrugs capable of increasing the drugs’ bioavailability and reducing side-effects has been developed by Carnegie Mellon University researchers. Their...
  • News - 12 Jun 2013
    UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny ‘biosensors’ along with new advanced imaging...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.